M&G Investment Management
ARCT icon

M&G Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

M&G Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,209
Closed -$394K – 499
2021
Q3 		$394K Buy
+8,209
New +$368K ﹤0.01% 690

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M&G Investment Management's ARCT Position: Q4 2021 in Review

M&G Investment Management sold out of Arcturus Therapeutics (ARCT) in Q4 2021, closing a stake of 8,209 shares — an estimated $394K sold.

M&G Investment Management first reported a position in ARCT in Q3 2021 and held it in 1 quarter. The position peaked at $394K in Q3 2021. 139 funds tracked by Wall St. Rank hold ARCT as of Q4 2021.

  • M&G Investment Management reported no remaining Arcturus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 8,209 Arcturus Therapeutics shares in Q4 2021, an estimated $394K.
  • M&G Investment Management first reported a position in Arcturus Therapeutics in Q3 2021 and held it in 1 quarter.
  • M&G Investment Management's Arcturus Therapeutics position peaked at $394K in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.